Marcella Gulisano

1.1k total citations
31 papers, 632 citations indexed

About

Marcella Gulisano is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Marcella Gulisano has authored 31 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Marcella Gulisano's work include Estrogen and related hormone effects (11 papers), Cancer Treatment and Pharmacology (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Marcella Gulisano is often cited by papers focused on Estrogen and related hormone effects (11 papers), Cancer Treatment and Pharmacology (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Marcella Gulisano collaborates with scholars based in Italy, United States and Czechia. Marcella Gulisano's co-authors include Bernardo Bonanni, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, Harriet Johansson, Franca Formelli, Davide Serrano, Massimiliano Cazzaniga, Sara Gandini, Serena Mora and Paolo Magni and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Marcella Gulisano

30 papers receiving 608 citations

Peers

Marcella Gulisano

ONCOL

PRM

GENET

Céline Pallaud Switzerland

Nazan Günel Türkiye

Reiko Masunaga Japan

Immacolata Capasso Italy

Po‐Han Lin Taiwan

Tsukasa Teramoto Japan

Vasiliki Michalaki Greece

C Andreoli Italy

Fulvio Brema Italy

Ryoji Sassa Japan

Céline Pallaud Switzerland

Marcella Gulisano

275 ×1.0

ONCOL

128 ×0.7

PRM

235 ×1.4

91 ×0.6

GENET

114 ×0.7

Citations per year, relative to Marcella Gulisano Marcella Gulisano (= 1×) peers Céline Pallaud

Countries citing papers authored by Marcella Gulisano

Since Specialization

Citations

This map shows the geographic impact of Marcella Gulisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcella Gulisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcella Gulisano more than expected).

Fields of papers citing papers by Marcella Gulisano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcella Gulisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcella Gulisano. The network helps show where Marcella Gulisano may publish in the future.

Co-authorship network of co-authors of Marcella Gulisano

This figure shows the co-authorship network connecting the top 25 collaborators of Marcella Gulisano. A scholar is included among the top collaborators of Marcella Gulisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcella Gulisano. Marcella Gulisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, et al.. (2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers. 16(7). 1411–1411.

DeCensi, Andrea, Matteo Puntoni, Franca Avino, et al.. (2019). Abstract GS3-01: A randomized placebo controlled phase III trial of low dose tamoxifen for the prevention of recurrence in women with operated hormone sensitive breast ductal or lobular carcinoma in situ. Cancer Research. 79(4_Supplement). GS3–1. 5 indexed citations

Muraca, Maria Grazia, et al.. (2015). Role of dance as part of adapted physical activity program in breast cancer survivors: a pilot study. Medicina dello Sport. 68(4). 591–599. 4 indexed citations

Johansson, Harriet, Bernardo Bonanni, Sara Gandini, et al.. (2013). Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide. Breast Cancer Research and Treatment. 142(3). 569–578. 17 indexed citations

Puntoni, Matteo, Bernardo Bonanni, Giuseppe D’Aiuto, et al.. (2013). Randomized, placebo controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia.. Journal of Clinical Oncology. 31(15_suppl). TPS1610–TPS1610. 1 indexed citations

Macis, Debora, Sara Gandini, Aliana Guerrieri‐Gonzaga, et al.. (2011). Abstract 3671: Associations between a polymorphic locus in the promoter region of the IGFBP-3 gene, circulating IGFs, mammographic breast density and survival in a 2×2 trial of low-dose tamoxifen and fenretinide in premenopausal women. Cancer Research. 71(8_Supplement). 3671–3671. 1 indexed citations

DeCensi, Andrea, Chris Robertson, Aliana Guerrieri‐Gonzaga, et al.. (2009). Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women. Journal of Clinical Oncology. 27(23). 3749–3756. 87 indexed citations

DeCensi, Andrea, Aliana Guerrieri‐Gonzaga, Marina Elena Cazzaniga, et al.. (2004). A randomized 2×2 biomarker trial of low-dose tamoxifen and fenretinide in premenopausal women at-high risk for breast cancer. Journal of Clinical Oncology. 22(14_suppl). 1001–1001. 1 indexed citations

Gridelli, Cesare, L. Frontini, Federica Perrone, et al.. (2000). Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. British Journal of Cancer. 83(6). 707–714. 51 indexed citations

10.

Pacini, Simone, Stefano Aterini, Patrizia Pacini, et al.. (1999). Influence of static magnetic field on the antiproliferative effects of vitamin D on human breast cancer cells.. PubMed. 11(6). 265–71. 12 indexed citations

11.

Gion, Massimo, R. Mione, Gianni Cappelli, et al.. (1995). Tumor markers in breast cancer follow-up: A potentially useful parameter still awaiting definitive assessment. Annals of Oncology. 6. S31–S35. 23 indexed citations

12.

Gion, Massimo, R. Mione, Giulio Vignati, et al.. (1993). Variability of Tumor Markers in the Follow-Up of Patients Radically Resected for Breast Cancer. Tumor Biology. 14(6). 325–333. 11 indexed citations

13.

Ardizzoni, Andrea, R. Rosso, Vittorio Fusco, et al.. (1991). Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study. Cancer. 67(12). 2984–2987. 66 indexed citations

14.

Pronzato, P., D. Amoroso, Gianfilippo Bertelli, et al.. (1989). Phase II study of lonidamine in metastatic breast cancer. British Journal of Cancer. 59(2). 251–253. 23 indexed citations

15.

Figoli, F., et al.. (1989). Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatin.. Journal of Clinical Oncology. 7(5). 680–681. 3 indexed citations

16.

Ardizzoni, Andrea, P. Pronzato, Lazzaro Repetto, et al.. (1988). Phase II Trial of Oral Idarubicin in Advanced Non-Small Cell Lung Cancer (NSCLC). Cancer Investigation. 6(4). 409–411. 8 indexed citations

17.

Ardizzoni, Andrea, Marcella Gulisano, P. Pronzato, et al.. (1987). Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.. PubMed. 71(12). 1311–2. 10 indexed citations

18.

Pronzato, P., D. Amoroso, Andrea Ardizzoni, et al.. (1987). Sequential Administration of Cyclophosphamide, Methotrexate, 5-Fluorouracil, and Folinic Acid as Salvage Treatment in Metastatic Breast Cancer. American Journal of Clinical Oncology. 10(5). 404–406. 6 indexed citations

19.

Rosso, Roberta, Andrea Ardizzoni, Pierfranco Conté, et al.. (1987). Phase II trials of idarubicin, a new anthracycline.. PubMed. 6(2 Suppl). 694–694. 1 indexed citations

20.

Pronzato, P., Andrea Ardizzoni, Pierfranco Conté, et al.. (1986). A phase II study of mitoxantrone in advanced breast cancer.. PubMed. 5(3). 150–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact